These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9201565

  • 1. Plasma concentrations of vigabatrin in epileptic patients.
    Sánchez-Alcaraz A, Quintana B, Rodriguez I, López E.
    J Clin Pharm Ther; 1996 Dec; 21(6):393-8. PubMed ID: 9201565
    [Abstract] [Full Text] [Related]

  • 2. Newer antiepileptic drugs as monotherapy: data on vigabatrin.
    Fisher R, Kälviäinen R, Tanganelli P, Regesta G.
    Neurology; 1996 Jul; 47(1 Suppl 1):S2-5. PubMed ID: 8677032
    [Abstract] [Full Text] [Related]

  • 3. Effect of vigabatrin on the pharmacokinetics of carbamazepine.
    Sánchez-Alcaraz A, Quintana MB, López E, Rodríguez I, Llopis P.
    J Clin Pharm Ther; 2002 Dec; 27(6):427-30. PubMed ID: 12472982
    [Abstract] [Full Text] [Related]

  • 4. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.
    Kälviäinen R, Aikiä M, Saukkonen AM, Mervaala E, Riekkinen PJ.
    Arch Neurol; 1995 Oct; 52(10):989-96. PubMed ID: 7575227
    [Abstract] [Full Text] [Related]

  • 5. Vigabatrin dosing during haemodialysis.
    Bachmann D, Ritz R, Wad N, Haefeli WE.
    Seizure; 1996 Sep; 5(3):239-42. PubMed ID: 8902928
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy and cognitive effects of vigabatrin.
    Ylinen A, Kälviäinen R, Riekkinen PJ.
    Acta Neurol Scand Suppl; 1995 Sep; 162():47-50. PubMed ID: 7495191
    [Abstract] [Full Text] [Related]

  • 7. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
    Armijo JA, Cuadrado A, Bravo J, Arteaga R.
    Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vigabatrin and lamotrigine in refractory epilepsy.
    Stolarek I, Blacklaw J, Forrest G, Brodie MJ.
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):921-4. PubMed ID: 8057114
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures.
    Beran RG, Berkovic SF, Buchanan N, Danta G, Mackenzie R, Schapel G, Sheean G, Vajda F.
    Seizure; 1996 Dec; 5(4):259-65. PubMed ID: 8952010
    [Abstract] [Full Text] [Related]

  • 11. [Concurrence of short and long lasting episodes of nocturnal paroxysmal dystonia in an epileptic patient].
    Rodríguez Moreno E, Acilona V, Boza F, Ortega JE, Carballo M, Palomino A, Arenas C.
    Neurologia; 1997 Mar; 12(3):136-9. PubMed ID: 9198455
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.
    French JA, Mosier M, Walker S, Sommerville K, Sussman N.
    Neurology; 1996 Jan; 46(1):54-61. PubMed ID: 8559421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study.
    Feucht M, Brantner-Inthaler S.
    Epilepsia; 1994 Jan; 35(5):993-8. PubMed ID: 7925171
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Albani F, Riva R, Candela C, Mohamed S, Baruzzi A.
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M, Riva R, Albani F, Avoni P, Baruzzi A.
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.